from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3734c/tgs2

LFCtreatmentdescriptionclass of inhibitor

-0.542

Amikacinug/mL Amikacintranslation

-1.468

Cap5-10ug/mL Capreomycintranslation

-1.002

Rox10-50 ug/mL Roxithromycintranslation

-0.629

SM2-5 ug/mL Streptomycintranslation

0.073

Tet5-10 ug/mL Tetracyclinetranslation

1.611

Rif0.2-5ug/mL Rifampicintranscription

-0.034

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.844

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.942

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.133

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.172

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.910

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.332

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.091

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.165

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.507

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.588

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.179

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.256

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.371

KCN5-20 ug/mL Potassium cyaniderespiration

-0.457

NaN30.2-2 mM Sodium aziderespiration

0.295

Nigericin50 uM Nigericinrespiration

1.257

TRC10-150 ug/mL Triclosanrespiration

0.148

TRZ10-25 ug/mL Thioridazinerespiration

-0.694

Valinomycin0.5-10 uM Valinomycinrespiration

-0.936

ZnSO42 mM ZnSO4respiration

0.071

menadione6-10 ug/mL Menadionerespiration

-0.213

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.602

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.294

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.702

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.207

NRP_1Non-replicating persistence stage 1dosRassociated

-0.740

Amp0.2mg/mL AmpicillincellWall

-0.455

Cephalexin20-100 ug/mL CephalexincellWall

-1.061

Cerulenin0.32-5 ug/mL CerulenincellWall

1.115

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.445

EMB10-20 ug/mL EthambutolcellWall

-0.441

Eta12-40 ug/mL EthionamidecellWall

-0.785

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.111

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.615

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.933

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.803

BZA0.12 mg/mL BenzamidearomaticAmides

0.474

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.021

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.512

H2O24 mM hydrogen peroxideDNAdamaging

-0.716

Levo10 ug/mL LevofloxacinDNAdamaging

-0.440

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.576

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.375

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.166

UVUV-irradiationDNAdamaging

1.418

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.420

Antimycin12.5-50 ug/mL Antimycin A?

-0.245

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.991

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.472

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.545

PA8240.2-2 ug/mL PA-824?

-0.089

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.103

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.398

Verapamil50 uM Verapamil?

0.434

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.378

methoxatin10-20 ug/mL Methoxatin?